Dentsply Sirona, The Dental Solutions Company™, today announced that it signed an agreement to acquire OraMetrix, an industry provider of innovative 3-D technology solutions designed to improve the predictability and efficiency of orthodontic care. This will further enable Dentsply Sirona to provide a total orthodontic solution, to include full arch clear aligners for our customers.
Today, Dentsply Sirona announced the signing of a definitive agreement to acquire OraMetrix, a leading industry provider of innovative 3-D technology solutions improving the quality and efficiency of orthodontic care. OraMetrix offers an advanced, CAD platform developed for dental professionals to deliver consistently predictable orthodontic outcomes. The acquisition, in combination with GAC’s bracket expertise and Dentsply Sirona’s digital technologies, will enable Dentsply Sirona to provide a comprehensive orthodontic offering that will include a full arch clear aligner solution.
Brad Clatt, Group Vice President, Dentsply Sirona Orthodontics commented: “Dentsply Sirona’s mission is to empower dental professionals to provide better, safer, faster dental care. OraMetrix has spent over a decade committed to that same clinical approach. This acquisition brings an advanced digital diagnostic and treatment planning system, that will provide clinicians the flexibility, speed, and control they need to treat their patients with multiple modalities on a single platform. We believe this platform positions us very well for the future as an end-to-end total orthodontic solution provider.”
Among its innovative products and services, OraMetrix offers a powerful, software platform that integrates multiple diagnostic media, including CBCT, Cephalometric, Panoramic, Optical, and Facial data. Following the acquisition, Dentsply Sirona will be able to provide an end-to-end digital workflow with a comprehensive range of devices to enable dental professionals to match their patient’s growing demands for aesthetics and speed of treatment.
OraMetrix will be a complementary part of Dentsply Sirona’s orthodontics business unit and strengthens Dentsply Sirona’s overall portfolio offering as The Dental Solutions Company™.
OraMetrix is the leading industry provider of innovative 3-D technology solutions improving the quality and efficiency of orthodontic care. Its proprietary technology, the SureSmile system, represents a significant leap forward in orthodontics. SureSmile allows the use of precision digital tools throughout all phases of the orthodontic treatment process – diagnosis, treatment planning and monitoring, and arch-wire customization. For doctors, SureSmile offers more precision, efficiency and control, while patients experience shorter treatment times, less overall discomfort and fewer office visits. The result is an orthodontic treatment system that delivers unparalleled results for patients and doctors alike. OraMetrix, founded in 1998, has approximately 130 employees in the United States, Germany, and Australia.
ABOUT DENTSPLY SIRONA
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with a 130-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. As The Dental Solutions Company, Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dentistry. Dentsply Sirona’s global headquarters is located in York, Pennsylvania, and the international headquarters is based in Salzburg, Austria. The company’s shares are listed in the United States on NASDAQ under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast”, and similar words and expressions. However, these words are not the exclusive means of identifying such statements. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the Company’s products, the possibility of changing economic, market and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the Company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.
Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.